Pharmaceuticals that mimic hormones now provide effective medical tools to combat obesity. Their long-term effects on society remain to be seen.

From surgery to supplements, GLP-1 medications are radically evolving the beauty space. We unpack the latest innovations.

Novo Nordisk lost billions in value because it failed to anticipate the risk posed by the introduction of its blockbuster ...

The company said the weight loss and diabetes treatment drug failed to show any significant reduction in the progression of ...

She did it her way. Kathy Bates defended the methods she used to lose 100 pounds in a new interview with Variety. “People say, ‘Well, it was the Ozempic.’ F–k you, it was the Ozempic!” the 77-year-old ...

A pill version of Novo Nordisk A/S’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot ...

Some experts cited the case of Slentrol, an older weight loss drug for dogs made by Pfizer’s animal health division (which ...

The actress said she made lifestyle changes over the years and then used Ozempic to help lose the last 15 to 20 lbs. Kathy Bates is setting the record straight when it comes to her 100-lb. weight loss ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Novo Nordisk A/S is slashing the cost of Ozempic for cash-paying patients after the diabetes shot became the poster child for high US drug prices. Patients can now get Ozempic for $499 a month - about ...